-
1
-
-
0031564954
-
p73 is a simian [correction of human] p53-related protein that can induce apoptosis
-
Jost CA, Marin MC, and Kaelin WG Jr. p73 is a simian [correction of human] p53-related protein that can induce apoptosis. Nature (Lond) 1997;389:191-4.
-
(1997)
Nature (Lond)
, vol.389
, pp. 191-194
-
-
Jost, C.A.1
Marin, M.C.2
Kaelin Jr., W.G.3
-
2
-
-
0036674617
-
Live or let die: The cell's response to p53
-
Vousden KH, Lu X. Live or let die: the cell's response to p53. Nat Rev Cancer 2002;2:594-604.
-
(2002)
Nat Rev Cancer
, vol.2
, pp. 594-604
-
-
Vousden, K.H.1
Lu, X.2
-
3
-
-
0032533514
-
The potential tumor suppressor p73 differentially regulates cellular p53 target genes
-
Zhu J, Jiang J, Zhou W, Chen X. The potential tumor suppressor p73 differentially regulates cellular p53 target genes. Cancer Res 1998;58:5061-5.
-
(1998)
Cancer Res
, vol.58
, pp. 5061-5065
-
-
Zhu, J.1
Jiang, J.2
Zhou, W.3
Chen, X.4
-
4
-
-
0033600240
-
Interaction of c-Abl and p73α and their collaboration to induce apoptosis
-
Agami R, Blandino G, Oren M, Shaul Y. Interaction of c-Abl and p73α and their collaboration to induce apoptosis. Nature (Lond) 1999;399:809-13.
-
(1999)
Nature (Lond)
, vol.399
, pp. 809-813
-
-
Agami, R.1
Blandino, G.2
Oren, M.3
Shaul, Y.4
-
5
-
-
0033600234
-
The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damage
-
Gong JG, Costanzo A, Yang HQ, et al. The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damage. Nature (Lond) 1999;399: 806-9.
-
(1999)
Nature (Lond)
, vol.399
, pp. 806-809
-
-
Gong, J.G.1
Costanzo, A.2
Yang, H.Q.3
-
6
-
-
10744230945
-
p53 polymorphism influences response in cancer chemotherapy via modulation of p73-dependent apoptosis
-
Bergamaschi D, Gasco M, Hiller L, et al. p53 polymorphism influences response in cancer chemotherapy via modulation of p73-dependent apoptosis. Cancer Cell 2003;3:387-402.
-
(2003)
Cancer Cell
, vol.3
, pp. 387-402
-
-
Bergamaschi, D.1
Gasco, M.2
Hiller, L.3
-
7
-
-
0034609798
-
Role for the p53 homologue p73 in E2F-1-induced apoptosis
-
Irwin M, Marin MC, Phillips AC, et al. Role for the p53 homologue p73 in E2F-1-induced apoptosis. Nature (Lond) 2000;407:645-8.
-
(2000)
Nature (Lond)
, vol.407
, pp. 645-648
-
-
Irwin, M.1
Marin, M.C.2
Phillips, A.C.3
-
8
-
-
0034609864
-
A common E2F-1 and p73 pathway mediates cell death induced by TCR activation
-
Lissy NA, Davis PK, Irwin M, et al. A common E2F-1 and p73 pathway mediates cell death induced by TCR activation. Nature (Lond) 2000;407:642-5.
-
(2000)
Nature (Lond)
, vol.407
, pp. 642-645
-
-
Lissy, N.A.1
Davis, P.K.2
Irwin, M.3
-
9
-
-
0033666776
-
Role of the p53-homologue p73 in E2F1-induced apoptosis
-
Stiewe T, Putzer BM. Role of the p53-homologue p73 in E2F1-induced apoptosis. Nat Genet 2000;26:464-9.
-
(2000)
Nat Genet
, vol.26
, pp. 464-469
-
-
Stiewe, T.1
Putzer, B.M.2
-
10
-
-
0035815677
-
Oncogenes induce and activate endogenous p73 protein
-
Zaika A, Irwin M, Sansome C, Moll UM. Oncogenes induce and activate endogenous p73 protein. J Biol Chem 2001;276:11310-6.
-
(2001)
J Biol Chem
, vol.276
, pp. 11310-11316
-
-
Zaika, A.1
Irwin, M.2
Sansome, C.3
Moll, U.M.4
-
12
-
-
17544363909
-
p73-deficient mice have neurological, pheromonal and inflammatory defects but lack spontaneous tumours
-
Yang A, Walker N, Bronson R, et al. p73-deficient mice have neurological, pheromonal and inflammatory defects but lack spontaneous tumours. Nature (Lond) 2000;404:99-103.
-
(2000)
Nature (Lond)
, vol.404
, pp. 99-103
-
-
Yang, A.1
Walker, N.2
Bronson, R.3
-
13
-
-
0035966345
-
p53, p63 and p73-solos, alliances and feuds among family members
-
Moll UM, Erster S, Zaika A. p53, p63 and p73-solos, alliances and feuds among family members. Biochim Biophys Acta 2001;1552:47-59.
-
(2001)
Biochim Biophys Acta
, vol.1552
, pp. 47-59
-
-
Moll, U.M.1
Erster, S.2
Zaika, A.3
-
14
-
-
0034647718
-
An anti-apoptotic role for the p53 family member, p73, during developmental neuron death
-
Pozniak CD, Radinovic S, Yang A, McKeon F, Kaplan DR, Miller, FD. An anti-apoptotic role for the p53 family member, p73, during developmental neuron death. Science (Wash D C) 2000;289:304-6.
-
(2000)
Science (Wash D C)
, vol.289
, pp. 304-306
-
-
Pozniak, C.D.1
Radinovic, S.2
Yang, A.3
McKeon, F.4
Kaplan, D.R.5
Miller, F.D.6
-
15
-
-
0036468249
-
Possible oncogenic potential of DeltaNp73: A newly identified isoform of human p73
-
Ishimoto O, Kawahara C, Enjo K, Obinata M, Nukiwa T, Ikawa S. Possible oncogenic potential of DeltaNp73: a newly identified isoform of human p73. Cancer Res 2002;62:636-41.
-
(2002)
Cancer Res
, vol.62
, pp. 636-641
-
-
Ishimoto, O.1
Kawahara, C.2
Enjo, K.3
Obinata, M.4
Nukiwa, T.5
Ikawa, S.6
-
16
-
-
0030812331
-
Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers
-
Kaghad M, Bonnet H, Yang A, Creancier L, Biscan JC, Valent A, et al. Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers. Cell 1997;90:809-19.
-
(1997)
Cell
, vol.90
, pp. 809-819
-
-
Kaghad, M.1
Bonnet, H.2
Yang, A.3
Creancier, L.4
Biscan, J.C.5
Valent, A.6
-
17
-
-
0036203514
-
Autoinhibitory regulation of p73 by Delta Np73 to modulate cell survival and death through a p73-specific target element within the Delta Np73 promoter
-
Nakagawa T, Takahashi M, Ozaki T, et al. Autoinhibitory regulation of p73 by Delta Np73 to modulate cell survival and death through a p73-specific target element within the Delta Np73 promoter. Mol Cell Biol 2002;22:2575-85.
-
(2002)
Mol Cell Biol
, vol.22
, pp. 2575-2585
-
-
Nakagawa, T.1
Takahashi, M.2
Ozaki, T.3
-
18
-
-
0036628511
-
Transactivation-deficient DeltaTA-p73 acts as an oncogene
-
Stiewe T, Zimmermann S, Frilling A, Esche H, Putzer BM. Transactivation-deficient DeltaTA-p73 acts as an oncogene. Cancer Res 2002;62:3598-602.
-
(2002)
Cancer Res
, vol.62
, pp. 3598-3602
-
-
Stiewe, T.1
Zimmermann, S.2
Frilling, A.3
Esche, H.4
Putzer, B.M.5
-
19
-
-
0037119631
-
ΔNp73, a dominant-negative inhibitor of wild-type p53 and TAp73, is up-regulated in human tumors
-
Zaika AI, Slade N, Erster SH, et al. ΔNp73, a dominant-negative inhibitor of wild-type p53 and TAp73, is up-regulated in human tumors. J Exp Med 2002;196: 765-80.
-
(2002)
J Exp Med
, vol.196
, pp. 765-780
-
-
Zaika, A.I.1
Slade, N.2
Erster, S.H.3
-
20
-
-
17744386129
-
Transactivation-deficient p73alpha (p73Deltaexon2) inhibits apoptosis and competes with p53
-
Fillippovich I, Sorokina N, Gatei M, et al. Transactivation-deficient p73alpha (p73Deltaexon2) inhibits apoptosis and competes with p53. Oncogene 2001;20: 514-22.
-
(2001)
Oncogene
, vol.20
, pp. 514-522
-
-
Fillippovich, I.1
Sorokina, N.2
Gatei, M.3
-
21
-
-
0037134475
-
Transactivation-deficient Delta TA-p73 inhibits p53 by direct competition for DNA binding: Implications for tumorigenesis
-
Stiewe T, Theseling CC, Putzer BM. Transactivation-deficient Delta TA-p73 inhibits p53 by direct competition for DNA binding: implications for tumorigenesis. J Biol Chem 2002;277:14177-85.
-
(2002)
J Biol Chem
, vol.277
, pp. 14177-14185
-
-
Stiewe, T.1
Theseling, C.C.2
Putzer, B.M.3
-
22
-
-
18244402691
-
Human delta Np73 regulates a dominant negative feedback loop for TAp73 and p53
-
Grob TJ, Novak U, Maisse C, et al. Human delta Np73 regulates a dominant negative feedback loop for TAp73 and p53. Cell Death Differ 2001;8:1213-23.
-
(2001)
Cell Death Differ
, vol.8
, pp. 1213-1223
-
-
Grob, T.J.1
Novak, U.2
Maisse, C.3
-
23
-
-
0042977668
-
ΔNp73 facilitates cell immortalization and cooperates with oncogenic Ras in cellular transformation in vivo
-
Petrenko O, Zaika A, Moll UM. ΔNp73 facilitates cell immortalization and cooperates with oncogenic Ras in cellular transformation in vivo. Mol Cell Biol 2003;23: 5540-55.
-
(2003)
Mol Cell Biol
, vol.23
, pp. 5540-5555
-
-
Petrenko, O.1
Zaika, A.2
Moll, U.M.3
-
24
-
-
0038190875
-
Inactivation of the RB tumor supressor gene by oncogenic isoforms of the p53 family member p73
-
Stiewe T, Stanelle J, Theseling CC, Pollmeier B, Beitzinger M, Putzer BM. Inactivation of the RB tumor supressor gene by oncogenic isoforms of the p53 family member p73. J Biol Chem 2003;278:14230-6.
-
(2003)
J Biol Chem
, vol.278
, pp. 14230-14236
-
-
Stiewe, T.1
Stanelle, J.2
Theseling, C.C.3
Pollmeier, B.4
Beitzinger, M.5
Putzer, B.M.6
-
25
-
-
0036005908
-
Expression of ΔNp73 is a molecular marker for adverse outcome in neuroblastoma patients
-
Casciano I, Mazzocco K, Boni L, et al. Expression of ΔNp73 is a molecular marker for adverse outcome in neuroblastoma patients. Cell Death Differ 2002;9:246-51.
-
(2002)
Cell Death Differ
, vol.9
, pp. 246-251
-
-
Casciano, I.1
Mazzocco, K.2
Boni, L.3
-
26
-
-
0024830707
-
Quantitative comparison of mRNA levels in mammalian tissues: 28S ribosomal RNA level as an accurate internal control
-
de Leeuw WJ, Slagboom PE, Vijg J. Quantitative comparison of mRNA levels in mammalian tissues: 28S ribosomal RNA level as an accurate internal control. Nucleic Acids Res 1989;17:10137-8.
-
(1989)
Nucleic Acids Res
, vol.17
, pp. 10137-10138
-
-
De Leeuw, W.J.1
Slagboom, P.E.2
Vijg, J.3
-
27
-
-
0029043805
-
A simple p53 functional assay for screening cell lines, blood, and tumors
-
Flaman JM, Frebourg T, Moreau V, et al. A simple p53 functional assay for screening cell lines, blood, and tumors. Proc Natl Acad Sci USA 1995;92:3963-7.
-
(1995)
Proc Natl Acad Sci USA
, vol.92
, pp. 3963-3967
-
-
Flaman, J.M.1
Frebourg, T.2
Moreau, V.3
-
28
-
-
0031766420
-
Expression level, allelic origin, and mutation analysis of the p73 gene in neuroblastoma tumors and cell lines
-
Kovalev S, Marchenko N, Swendeman S, LaQuaglia M, Moll UM. Expression level, allelic origin, and mutation analysis of the p73 gene in neuroblastoma tumors and cell lines. Cell Growth Differ 1998;9:897-903.
-
(1998)
Cell Growth Differ
, vol.9
, pp. 897-903
-
-
Kovalev, S.1
Marchenko, N.2
Swendeman, S.3
LaQuaglia, M.4
Moll, U.M.5
-
29
-
-
0037130279
-
Control of alternative splicing by antisense oligonucleotides as a potential chemotherapy: Effects on gene expression
-
Mercatante, DR, and Kole R. Control of alternative splicing by antisense oligonucleotides as a potential chemotherapy: effects on gene expression. Biochim Biophys Acta 2002;1587:126-32.
-
(2002)
Biochim Biophys Acta
, vol.1587
, pp. 126-132
-
-
Mercatante, D.R.1
Kole, R.2
-
30
-
-
0037130473
-
p53 induces the expression of its antagonist p73 AN, establishing an autoregulatory feedback loop
-
Kartasheva NN, Contente A, Lenz-Stoppler C, Roth J, Dobbelstein M. p53 induces the expression of its antagonist p73 AN, establishing an autoregulatory feedback loop. Oncogene 2002;21:4715-27.
-
(2002)
Oncogene
, vol.21
, pp. 4715-4727
-
-
Kartasheva, N.N.1
Contente, A.2
Lenz-Stoppler, C.3
Roth, J.4
Dobbelstein, M.5
-
31
-
-
0037161921
-
DN-p73 is activated after DNA damage in a p53-dependent manner to regulate p53-induced cell cycle arrest
-
Vossio S, Palescandolo E, Pediconi N, et al. DN-p73 is activated after DNA damage in a p53-dependent manner to regulate p53-induced cell cycle arrest. Oncogene 2002;21:3796-803.
-
(2002)
Oncogene
, vol.21
, pp. 3796-3803
-
-
Vossio, S.1
Palescandolo, E.2
Pediconi, N.3
-
32
-
-
1542359564
-
ΔNp73 stabilises TAp73 proteins but compromises their function due to inhibitory hetero-oligomer formation
-
Dec 12 [Epub ahead of print]. 2003;doi:10.1038/sj.cdd 4401335
-
Slade N, Zaika AI, Erster S, Moll UM. ΔNp73 stabilises TAp73 proteins but compromises their function due to inhibitory hetero-oligomer formation. Cell Death Differ [serial on the Internet]. 2003 Dec 12 [Epub ahead of print]. 2003;doi:10.1038/sj.cdd. 4401335.
-
(2003)
Cell Death Differ [Serial on the Internet]
-
-
Slade, N.1
Zaika, A.I.2
Erster, S.3
Moll, U.M.4
-
33
-
-
0029049828
-
Wild-type p53 protein undergoes cytoplasmic sequestration in undifferentiated neuroblastomas but not in differentiated tumors
-
Moll UM, LaQuaglia M, Benard J, Riou G. Wild-type p53 protein undergoes cytoplasmic sequestration in undifferentiated neuroblastomas but not in differentiated tumors. Proc Natl Acad Sci USA 1995;92:4407-11.
-
(1995)
Proc Natl Acad Sci USA
, vol.92
, pp. 4407-4411
-
-
Moll, U.M.1
LaQuaglia, M.2
Benard, J.3
Riou, G.4
-
34
-
-
0037428078
-
Parc: A cytoplasmic anchor for p53
-
Nikolaev AY, Li M, Puskas N, Qin J, Gu W. Parc: a cytoplasmic anchor for p53. Cell 2003;112:29-40.
-
(2003)
Cell
, vol.112
, pp. 29-40
-
-
Nikolaev, A.Y.1
Li, M.2
Puskas, N.3
Qin, J.4
Gu, W.5
-
35
-
-
0035131701
-
A subset of tumor-derived mutant forms of p53 down-regulate p63 and p73 through a direct interaction with the p53 core domain
-
Gaiddon C, Lokshin M, Ahn J, Zhang T, Prives C. A subset of tumor-derived mutant forms of p53 down-regulate p63 and p73 through a direct interaction with the p53 core domain. Mol Cell Biol 2001;21:1874-87.
-
(2001)
Mol Cell Biol
, vol.21
, pp. 1874-1887
-
-
Gaiddon, C.1
Lokshin, M.2
Ahn, J.3
Zhang, T.4
Prives, C.5
-
36
-
-
0003527583
-
-
Philadelphia, PA: W.B. Saunders Co.
-
Cotran RS, Collins T, Robbins SL. Pathologic basis of diseases, 6th edition. Philadelphia, PA: W.B. Saunders Co.; 1999. p. 279.
-
(1999)
Pathologic Basis of Diseases, 6th Edition
, pp. 279
-
-
Cotran, R.S.1
Collins, T.2
Robbins, S.L.3
-
37
-
-
0037897280
-
Expression of p73 and c-Abl proteins in human ovarian carcinomas
-
Niyazi M, Ghazizadeh M, Konishi H, Kawanami O, Sugisaki Y, Araki T. Expression of p73 and c-Abl proteins in human ovarian carcinomas. J Nippon Med Sch 2003 70:234-42.
-
(2003)
J Nippon Med Sch
, vol.70
, pp. 234-242
-
-
Niyazi, M.1
Ghazizadeh, M.2
Konishi, H.3
Kawanami, O.4
Sugisaki, Y.5
Araki, T.6
-
38
-
-
0033754993
-
P73 gene expression in ovarian cancer tissues and cell lines
-
Chen CL, Ip SM, Cheng D, Wong LC, Ngan, HY. P73 gene expression in ovarian cancer tissues and cell lines. Clin Cancer Res 2000;6:3910-5.
-
(2000)
Clin Cancer Res
, vol.6
, pp. 3910-3915
-
-
Chen, C.L.1
Ip, S.M.2
Cheng, D.3
Wong, L.C.4
Ngan, H.Y.5
|